Selected Publications

Buckley KH, Dungan ME, Dinh K, Kelly GM, Hausler R, Bennett KE, Clay DG, Youngman JE, Majer AD, Beyries KA, Niccum BA, Shaffer SM, Karakasheva TA, Hamilton KE, Kochman ML, Ginsberg GG, Ahmad N, Maxwell KN, Katona BW: Gastric epithelium from BRCA1 and BRCA2 carriers harbors increased double-stranded DNA damage and enhanced growth potential. Mol Cancer Res March 2026.

Das KK, Reddy DN, Ginsberg GG. : Endoscopic Imaging of the Liver and Biliary Tract. Schiff, Maddrey and Reddy: Schiff’s Diseases of the Liver 13th edition. West Sussex, England, Wiley Ltd, 2026.

Tanes C, Li Y, Falk GW, Ginsberg GG, Wang KK, Iyer PG, Lightdale CJ, Del Portillo A, Lagana SM, Wang TC, Rustgi AK, Quante M, Jin Z, Wu GD, Friedman ES, Bittinger K, Li H, Abrams JA. : Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett's esophagus. Gut Microbes 17(1), Dec 2025.

Katona BW, Shukla A, Hu W, Nyul T, Dudzik C, Arvanitis A, Clay D, Dungan M, Weber M, Tu V, Hao F, Gan S, Chau L, Buchner AM, Falk GW, Jaffe DL, Ginsberg G, Palmer SN, Zhan X, Patterson AD, Bittinger K, Ni J.: Microbiota and metabolite-based prediction tool for colonic polyposis with and without a known genetic driver. Gut Microbes 17(1), Dec 2025.

Buckley KH, Dungan ME, Dinh K, Kelly GM, Hausler R, Bennett KE, Clay DG, Youngman JE, Majer AD, Beyries KA, Niccum BA, Shaffer SM, Karakasheva TA, Hamilton KE, Kochman ML, Ginsberg GG, Ahmad N, Maxwell KN, Katona BW. : Gastric epithelium from BRCA1 and BRCA2 carriers harbors increased double-stranded DNA damage and augmented growth. bioRxiv 10(1), Oct 2025.

Roy A, Sharma M, Kulkarni AV, Lakhtakia S, Singh AP, Kalapala R, Ginsberg GG, Reddy DN, Reddy KR.: Endohepatology: Evolving Indications, Challenges, Unmet Needs and Opportunities. Gastro Hep Adv 5(2), Oct 2025.

Perry NJ, Bhatte S, Triggs JR, Leung G, Ahmad N, Kochman M, Saumoy M, Ginsberg GG: Extended Surveillance After Piecemeal Endoscopic Mucosal Resection: A Safe Approach to Initial Surveillance in Low-Risk Patients. Gastrointest Endosc 103(4): 794-798, April 2025.

Panchal S, Mahmud N, Atkins JH, Kang H, Leto A, Goebel A, Trivedi N, Chatila A, Hsu WW, Ginsberg GG, Pickett-Blakeley O, Zandvakili I.: Endoscopy and Anesthesia Outcomes Associated with Glucagon-Like Peptide-1 Receptor Agonist use in Patients Undergoing Outpatient Upper Endoscopy. Gastrointest Endosc January 2025.

Katona BW, Shukla A, Hu W, Nyul T, Dudzik C, Arvanitis A, Clay D, Dungan M, Weber M, Tu V, Hao F, Gan S, Chau L, Buchner AM, Falk GW, Jaffe DL, Ginsberg G, Palmer SN, Zhan X, Patterson AD, Bittinger K, Ni J.: Microbiota and metabolite-based prediction tool for colonic polyposis with and without a known genetic driver. Gut Microbes December 2024.

Kumar A, Gwalani P, Iyer PG, Wang KK, Falk GW, Ginsberg GG, Lightdale CJ, Del Portillo A, Lagana SM, Li Y, Li H, Genkinger J, Jin Z, Rustgi AK, Wang TC, Wang HH, Quante M, Abrams JA.: Shifts in Serum Bile Acid Profiles Associated With Barrett's Esophagus and Stages of Progression to Esophageal Adenocarcinoma. Clin Transl Gastroenterol August 2024.